»

DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2004 archives
Click here to return to the current data set

DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.

Generic Name: adapalene

Summary for Generic Name: adapalene

Tradenames:1
Patents:2
Applicants:1
NDAs:3
Drug Master File Entries: see list11
Suppliers: see list5
Therapeutic Class:Dermatological Agents

Pharmacology for Ingredient: adapalene

Ingredient-typeRetinoids
Drug ClassRetinoid

Tentative approvals for ADAPALENE

Applicant Application No. Form Dosage
<disabled><disabled>GEL; TOPICAL0.3%

Clinical Trials for: adapalene

Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
Status: Completed Condition: Skin Manifestations

Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
Status: Completed Condition: Skin Manifestations

A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging
Status: Recruiting Condition: Photoaging; Photodamage

Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel
Status: Completed Condition: Acne Vulgaris

Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%
Status: Completed Condition: Acne Vulgaris

A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile Purpura
Status: Recruiting Condition: Senile Purpura

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Patented / Exclusive Use
Galderma Labs Lp
DIFFERIN
adapalene
CREAM; TOPICAL020748May 26, 2000RXYes4,717,720<disabled>
Galderma Labs Lp
DIFFERIN
adapalene
CREAM; TOPICAL020748May 26, 2000RXYesRE34440<disabled>METHOD OF USE OF THE DRUG SUBSTANCE
Galderma Labs Lp
DIFFERIN
adapalene
GEL; TOPICAL020380May 31, 1996RXYes4,717,720<disabled>
Galderma Labs Lp
DIFFERIN
adapalene
GEL; TOPICAL020380May 31, 1996RXYesRE34440<disabled>METHOD OF USE OF THE DRUG SUBSTANCE
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Sign up for a free trial

No commitment, no credit card required
First name
Last name
Email address

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639


`abc